SCHEMBL13544705

SCHEMBL13544705

CC(=O)C(C)(C)CCC(=O)NC1CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.46
HPGD P15428 2/20 0.44
ALDH1A1 P00352 2/20 0.42
GNAI3 P08754 1/20 0.41
GNAO1 P09471 1/20 0.41
GNAI1 P63096 1/20 0.41
HSD11B1 P28845 1/20 0.41
HDAC3 O15379 2/20 0.40
HDAC1 Q13547 2/20 0.40
HDAC2 Q92769 2/20 0.40
HDAC10 Q969S8 2/20 0.40
HDAC11 Q96DB2 2/20 0.40
HDAC8 Q9BY41 2/20 0.40
HDAC6 Q9UBN7 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
MAPT P10636 1/20 0.40
NCOR2 Q9Y618 1/20 0.40
SMYD3 Q9H7B4 2/20 0.39
CNR1 P21554 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13544500 0.85 ALDH1A1 (0.46) SMN1; SMN2HPGDALDH1A1GNAI3GNAO1
SCHEMBL22870418 0.82 SMN1; SMN2 (0.50) SMN1; SMN2HPGDALDH1A1GNAI3GNAO1
SCHEMBL13544707 0.81 HSD11B1 (0.50) SMN1; SMN2HPGDALDH1A1HSD11B1MEN1
SCHEMBL21131668 0.76 RAB9A (0.46) SMN1; SMN2HPGDALDH1A1GNAI3GNAO1
SCHEMBL15684107 0.76 SMN1; SMN2 (0.57) SMN1; SMN2HPGDALDH1A1GNAI3GNAO1
SCHEMBL10132085 0.75 SMN1; SMN2 (0.65) SMN1; SMN2HPGDALDH1A1GNAI3GNAO1
SCHEMBL9125344 0.74 HPGD (0.62) SMN1; SMN2HPGDALDH1A1HDAC3HDAC1
SCHEMBL13544828 0.74 SMN1; SMN2 (0.54) SMN1; SMN2HPGDALDH1A1GNAI3GNAO1
SCHEMBL22859123 0.73 EPHX2 (0.42) SMN1; SMN2HPGDALDH1A1GNAI3GNAO1
SCHEMBL20581686 0.71 SMN1; SMN2 (0.56) SMN1; SMN2HPGDALDH1A1GNAI3GNAO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7645771-B2 CCR5 antagonists as therapeutic agents SMITHKLINE BEECHAM CORP. (US) 2010-01-12 US disclosed
US-7645771-B2 CCR5 antagonists as therapeutic agents SMITHKLINE BEECHAM CORP. (US) 2010-01-12 US disclosed